Package Leaflet: Information for the User
Donopa 50%/50% Medical Compressed Gas
Nitrous Oxide / Oxygen
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the Package Leaflet
Donopa contains a prepared mixture of nitrous oxide (N2O) and oxygen (oxygen medicinal, O2), each constituting 50%, and should be used by inhaling the gas mixture.
Donopa can be used in adults and children over 1 month.
Effects of Donopa
Nitrous oxide constitutes 50% of the gas mixture. Nitrous oxide has an analgesic effect, reduces the sensation of pain, and increases the pain threshold. Nitrous oxide also has a relaxing and slightly calming effect. These effects are generated by the action of nitrous oxide on signaling substances present in the nervous system.
The effect of Donopa is less in children under three years.
The concentration of oxygen at 50%, which is approximately twice that in ambient air, guarantees a safe oxygen content in the inhaled gas.
Donopa should be used
For dental care, in the case of patients who suffer from anxiety.
Do not use Donopa:
Before using Donopa, you should inform your doctor if you have any of the following symptoms or signs:
Warnings and precautions
Consult your doctor or pharmacist before starting to use Donopa if:
Repeated or long-term use of nitrous oxide can increase the risk of vitamin B12 deficiency, which can cause damage to the bone marrow or nervous system. Your doctor may perform blood tests before and after treatment to assess the consequences of a possible vitamin B12 deficiency.
You should also inform your doctor if you have any of the following symptoms or signs:
You should breathe normally during inhalation.
Your doctor will decide if Donopa is suitable for you.
Using Donopa with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
If you are taking other medicines that affect the brain or brain function, such as benzodiazepines (tranquilizers) or morphine-type medications, you should inform your doctor, since Donopa can increase the effects of these medicines. In combination with other sedatives or medications that affect the central nervous system, Donopa increases the risk of side effects.
You should also inform your doctor if you are taking medications that contain methotrexate (for example, for rheumatoid arthritis), bleomycin (to treat cancer), nitrofurantoin, or similar antibiotics (to treat infections), or amiodarone (to treat heart diseases), since Donopa increases the adverse effects of these medications.
Donopa can be used during pregnancy if it is clinically necessary.
If Donopa is administered for a short period, it is not necessary to interrupt breast-feeding.
If you are pregnant or breast-feeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Driving and Using Machines
If you have been given Donopa without any other analgesic/sedative, for safety reasons, you should avoid driving, operating machinery, or performing complex tasks until you are fully recovered (at least 30 minutes).
Do not forget to ask your healthcare professional if it is safe for you to drive.
Donopa will always be administered in the presence of personnel familiar with this type of medication. The personnel will ensure that the Donopa supply is suitable for use and that the equipment is correctly configured. While using Donopa, you will be supervised to ensure that you are taking the medication safely. Once you finish using Donopa, you will continue to be supervised by competent personnel until you have recovered.
Follow the administration instructions of the medication indicated by your doctor exactly.
Your doctor will explain how to use Donopa, how it works, and what effects it may cause. If you are in doubt, ask your doctor.
Normally, Donopa is inhaled through a facial mask connected to a special valve, which means you will have full control over the gas flow based on your own breathing. The valve will only be open during breathing. Donopa can also be administered through a nasal mask.
Regardless of the mask used, you should breathe with normal intensity in the mask.
Once you finish using Donopa, you should rest and wait until you feel mentally recovered.
Safety Precautions
If you use more Donopa than you should
It is very unlikely that you will receive an excessive gas supply, since you control the gas flow yourself and the mixture is fixed (contains 50% nitrous oxide and 50% oxygen).
If you breathe more quickly than normal and, therefore, receive more nitrous oxide flow than you should with normal breathing, you may feel considerably tired and, to some extent, disoriented. In that case, you should immediately inform the medical personnel and interrupt the administration of the medication.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common(may affect up to 1 in 10 people)
Dizziness, mild headache, euphoria, nausea, and vomiting.
Uncommon(may affect up to 1 in 100 people)
Intense fatigue. Feeling of pressure in the middle ear, if Donopa is used for a prolonged period. This is because Donopa increases the pressure in the middle ear.
Abdominal swelling, due to Donopa slowly increasing the volume of gas in the intestines.
Frequency not known(available data do not allow an estimate of frequency)
Effects on the bone marrow that can cause anemia.
Effects on nervous functions, feeling of numbness and weakness, usually in the legs.
This is because nitrous oxide affects the metabolism of vitamin B12 and folic acid, thereby inhibiting an enzyme: methionine synthase.
Abnormal movements that usually occur after hyperventilation (increase in respiratory rate during inhalation).
Respiratory depression. You may also experience headache.
Psychiatric effects such as psychosis, confusion, anxiety, or addiction.
Generalized convulsions.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System for Human Use: www.notificaRAM.es.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date (Exp) that appears on the gas cylinder label. The expiry date is the last day of the month indicated.
Store between 0°C and 50°C. Do not freeze.
If it is suspected that Donopa has been stored at too low temperatures, the gas cylinders should be stored horizontally at a temperature above +10°C for at least 48 hours before use.
Keep away from flammable products.
Contact with flammable products can cause a fire.
Do not smoke or use open flames near Donopa.
Do not expose the product to intense heat.
If there is a risk of fire, move the gas cylinder to a safe place.
Keep the gas cylinder clean, dry, and free of oils and fats.
Keep the gas cylinder in a closed and reserved storage area for medical gases.
Store and transport with the valves closed.
Make sure the gas cylinder has not been damaged or dropped.
Inhaling vapors can cause drowsiness and dizziness.
Composition of Donopa
Appearance of Donopa and Contents of the Pack
Donopa is a colorless, odorless, and tasteless gas that is administered in a gas cylinder with a valve to control the gas flow. The cylinders can be made of steel or aluminum.
Pharmaceutical form: compressed medicinal gas.
The top of the gas cylinder is marked in white and blue (oxygen/nitrous oxide). The body of the gas cylinder is white (medicinal gas).
Package size in liters (135 bar) | 2 | 2.7 | 5 | 10 | 15 | 20 |
Package size in liters (185 bar) | 2 | 5 |
Not all pack sizes may be marketed.
Marketing Authorization Holder:
SOL FRANCE SUCURSAL EN ESPAÑA
Calle Yeso, num. 2
28500 Arganda del Rey - (Madrid)
Spain
Manufacturer
SOL France
ZI des Béthunes
8 Rue du Compas
95310 Saint Ouen l’Aumone
France
This medicine is authorized in the Member States of the European Economic Area under the following names:
Belgium: Antafil
Germany: Donopa
Austria: Donopa
Bulgaria: ??????
Croatia: Donopa
Slovenia: Donopa
Spain: Donopa
Greece: Donopa
Hungary: Donopa
Ireland: Donopa
Italy: Donopa
Luxembourg: Antafil
Netherlands: Donopa
United Kingdom: Donopa
Date of last revision of this leaflet: 11/2022
--------------------------------------------------------------------------------------------------------
The following information is intended exclusively for healthcare professionals:
Safety Instructions
Administration or repeated exposure to nitrous oxide can cause addiction. Precautions should be taken in the case of healthcare professionals who, due to their work, are exposed to nitrous oxide.
Nitrous oxide should be administered according to local guidelines.
Donopa should only be used in well-ventilated areas and in areas equipped with special equipment to evacuate excess gas. The formation of high atmospheric concentrations of nitrous oxide can be avoided by using an extraction system and ensuring good ventilation. High concentrations of nitrous oxide in the ambient air can cause adverse health effects in healthcare personnel or other individuals present in the vicinity. There are national guidelines regarding the concentration of nitrous oxide in the air that should not be exceeded, the so-called "health limit values", often expressed as TWA (time-weighted averageor time-weighted average concentration), which is the average value during a working day, and STEL (short-term exposure limitor short-term exposure limit), which is the average value during a shorter exposure.
These values should not be exceeded to ensure that personnel are not exposed to risks.
After use, the cylinder valve should be firmly closed. Depressurize the regulator or connection.